Tag Archives: imaging
Physiological Evidence of “Cancer Brain” Found
Using PET/CT scans, researchers looked at the brain function of 128 breast cancer patients. The study aimed to show that PET/CT is a useful tool to measure the presence of … Continue reading
Recurrent Ovarian Cancer: Use of Contrast-enhanced CT and PET/CT to Accurately Localize Tumor Recurrence and to Predict Patients’ Survival.
Purpose: To compare accuracy and interobserver variability in the detection and localization of recurrent ovarian cancer with contrast material-enhanced (CE) computed tomography (CT) and positron emission tomography (PET)/CT and determine … Continue reading
Recurrent Ovarian Cancer: Use of Contrast-enhanced CT and PET/CT to Accurately Localize Tumor Recurrence and to Predict Patients’ Survival
Purpose: To compare accuracy and interobserver variability in the detection and localization of recurrent ovarian cancer with contrast material–enhanced (CE) computed tomography (CT) and positron emission tomography (PET)/CT and determine … Continue reading
Role of PET/CT in Ovarian Cancer
OBJECTIVE. The purpose of this article is to review the role of FDG PET/CT in ovarian cancer, which is the leading cause of death among gynecologic cancers. CONCLUSION. FDG PET/CT … Continue reading
Can a Multimarker Assay Improve Screening for Ovarian Cancer?
Almost three quarters of ovarian cancer cases are diagnosed at advanced stages, making this disease the most lethal gynecologic malignancy in U.S. women. Using sera from a total of 1400 … Continue reading
Clinicians Believe That at Least Half of Their Patients Have Difficulty Paying for Treatment (NCCN)
Clinicians are in tune with the difficulties cost of care presents for their patients. According to a new NCCN Trends™ Survey, most clinicians believe that at least half of their … Continue reading
Combined positron emission tomography-computed tomography and tumor markers for detecting recurrent ovarian cancer (Arch Gynecol Obstet)
OBJECTIVE: To evaluate the accuracy of integrated FDG-PET/CT and tumor markers for the depiction of recurrent ovarian carcinoma. METHODS: Patients with pathologically proven ovarian cancer, who underwent cytoreductive surgery and … Continue reading
New frontiers for ovarian cancer risk evaluation: proteomics and contrast-enhanced ultrasound (AJR Am J Roentgenol)
OBJECTIVE: The grim ovarian cancer statistics are attributed to the fact that most women typically present with widespread disease at the time of initial diagnosis. Our current diagnostic tools, such … Continue reading
High-Resolution Sonographic Findings of Ovarian Granulosa Cell Tumors (J Ultrasound Med)
Objective. This study was performed to determine the high-resolution sonographic findings of ovarian granulosa cell tumors (GCTs) and to correlate the sonographic findings with the pathologic findings. Methods. A retrospective … Continue reading
MRI, CT, and PET/CT for Ovarian Cancer Detection and Adnexal Lesion Characterization (Am. J. of Roentgenology)
OBJECTIVE. The purpose of this article is to describe the role of MR, CT, and PET/CT in the detection of ovarian cancer and the evaluation of adnexal lesions. CONCLUSION. The … Continue reading
